Please login to the form below

Not currently logged in
Email:
Password:

Hanspeter Spek to retire from Sanofi

President of global operations will step down after 18 years at the pharma company

Hanspete Spek, SanofiSanofi's president of global oepraitons Hanspeter Spek is to retire.

His will step down in mid-2013 following 18 years service at the company he joined in 1985 as marketing director at Sanofi Pharma GmbH Germany.

Spek rose through the ranks , eventually being appointed to this current position in November, 2009.

“During his many years with Sanofi, Hanspeter has made an exceptional contribution to the success of the group and has helped bring Sanofi to the forefront of the industry,” said the company's CEO Christopher Viehbacher.

“His early recognition of growing opportunities in the emerging markets has contributed to the building of Sanofi's leading position there.”

During his time at Sanofi, he has helped with the success of several significant products, including bloodthinner Plavix, insulin Lantus and cancer drug Taxotere.

A succession plan is to be announced said Sanofi.

21st December 2012

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics